GARDEN CITY, NY, Nov. 07, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a next-generation biotech, genomics and diagnostics company, today announced that it intends to offer to sell ...

ProPhase Labs shares are trading lower by 50% during Friday's session. The company announced a 4.17 million share offering at ...

纽约州花园城 - 专注于生物技术、基因组学和诊断领域的ProPhase Labs, Inc. (NASDAQ: PRPH)周四宣布计划进行其普通股和可能的预付权证的承销公开发行。发行的具体条款和规模将取决于市场条件，公司并未保证其完成或时间。

ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next-generation biotech, genomics and diagnostics company, today announced the pricing of its underwritten public offering of 4,170, ...

在充满挑战的市场环境中，ProPhase Labs, Inc. (PRPH)的股价触及52周新低，达到1.99美元。这一最新跌幅凸显了该公司正经历的艰难时期，过去一年其股价已下跌55.27%。投资者一直密切关注ProPhase Labs，因为它正在应对一系列显著影响其市场估值的不利因素。52周新低作为公司业绩和投资者情绪的关键指标，标志着该股票在过去一年中的最低交易价格。随着ProPhase ...

ProPhase Labs (PRPH) announced that it intends to offer to sell shares of its common stock in an underwritten public offering. All of the ...

ThinkEquity acted as sole book running manager for the offering. Published first on TheFly – the ultimate source for real-time, ...

On Friday, ProPhase Labs Inc (PRPH) stock saw a decline, ending the day at $0.78 which represents a decrease of $-0.65 or -45.45% from the prior close of $1.43. The stock opened at $0.7 and touched a ...

Introduces DNA Expand Subscription Platform to Enrich Existing DNA Ancestry Data with Comprehensive Health Insights GARDEN CITY, NY, Nov. 04, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: PRPH) (the “Company” or ...

As of November 08, 2024, ProPhase Labs, Inc. had a $14.9 million market capitalization, putting it in the 8th percentile of companies in the Pharmaceuticals industry. ProPhase Labs, Inc. does not have ...

U.S. stocks were higher after the close on Friday, as gains in the Consumer Goods, Utilities and Financials sectors led ...